Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SynKIR-310 |
Trade Name | |
Synonyms | SynKIR 310|SynKIR310 |
Drug Descriptions |
Limited information is currently available on SynKIR-310, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD19 (Nov 2024). |
DrugClasses | CD19 Immune Cell Therapy 64 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SynKIR-310 | SynKIR-310 | 0 | 1 |